Alvarius Pharmaceuticals

Alvarius is an Irish bio-pharmaceutical company researching and developing unique therapies to target addiction through the pioneering use of 5-MeO-DMT medicines.

Alvarius aims to help patients overcome addictive substance-related behaviours with ground-breaking pharmaceutical solutions combined with tailored therapy. Together with our collaboration partners in University College Dublin, we are utilising the latest scientific methods to unlock the potential of psychedelics and associated therapy in treating addiction and other mental illnesses, and exploring the many associated benefits of these underused, misunderstood, and often stigmatised substances.

The therapy includes acute administration of 5-MeO-DMT coupled with expertly guided psychotherapy sessions designed to maximise the anti-addictive benefits of the psychedelic treatment.

By placing the power of recovery back in the hands of patients, our therapies can enable those suffering with stimulant addiction to retake control of their healing process.

Cutting-edge research into psychedelic treatments is reimagining the pharmaceutical approach to a wide-range of mental illnesses; Alvarius is pioneering study into the anti-addiction properties of 5-MeO-DMT and developing treatments that utilise the power of psychedelics to empower patients toward a life free from substance dependency.

We are at the precipice of harnessing the true healing potential of safe, natural psychedelics, and Alvarius is proud to be at the vanguard of establishing these incredible substances as widely used treatments in mental health.